It is a financial services private limited company based in Hyderabad, Telangana, India, established in 2020.
2020 | Hyderabad, Telangana, India | ActiveQemiq Pharma Private Limited, a active private limited company, was established on 20 July 2020 in Hyderabad, Telangana, India. Engaging in diversified financial services within the financial services sector, it holds CIN: U24100TG2020PTC141937. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹8.00 Cr and a paid-up capital of ₹6.00 Cr.
Formerly known as Arr Capital Investment Private Limited. Its leadership includes Nikhil Reddy Pasya (Director), Niranjan Dasari (Director). Past directors included Sravani Reddy Gantla, Rajasekhar Reddy Puchakayala, Pushpalatha Vustala. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 4-7-64/A1/1, Saraswathi Block, Triveni Complex,, Hyderabad, Telangana, 500013.
U43309TG2020PTC141937
141937
20 July 2020
₹8.00 Cr
₹6.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Qemiq Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nikhil Reddy Pasya | Director | 20 Jul 2020 | Current |
| Niranjan Dasari | Director | 20 Jul 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Jan 2023 | Past |
| Pramod Abcsdd | Director | 18 Jan 2023 | Past |
| Pramod Abcsdd | Director | 09 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Qemiq Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial improvement in profitability, with a 73.25% increase in profit. The company's net worth dipped by a decrease of 0.24%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Qemiq Pharma had a promoter holding of 97.50% and a public holding of 2.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Qemiq Pharma has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Qemiq Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Qemiq Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Qemiq Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Qemiq Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
The activity Nikhil Reddy Pasya was appointed as a Director was appointed as a Director on 20 Jul 2020 & has been associated with this company since 5 years 4 months . was completed.
Niranjan Dasari was appointed as a Director was appointed as a Director on 20 Jul 2020 & has been associated with this company since 5 years 4 months . was recorded as a recent event.
Qemiq Pharma Private Limited was registered on 20 Jul 2020 with Roc Hyderabad & aged 5 years 4 months as per MCA records. was recorded as a recent event.
The CIN of Qemiq Pharma Private Limited is U43309TG2020PTC141937.
Qemiq Pharma Private Limited is headquartered at 4-7-64/A1/1, Saraswathi Block, Triveni Complex,, Hyderabad, Telangana, 500013.
Qemiq Pharma Private Limited was incorporated on 20 July 2020.
The current directors of Qemiq Pharma Private Limited are
The primary industry of Qemiq Pharma Private Limited is Financial Services.
Qemiq Pharma Private Limited is unlisted.
The authorized capital of Qemiq Pharma Private Limited is ₹8.00 Cr, and the paid-up capital is ₹6.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX